Who is sponsoring NCT01439074?

NCT01439074 is sponsored by Molnlycke Health Care AB.

What condition does NCT01439074 study?

NCT01439074 studies Burn Injuries.

What drugs are being tested in NCT01439074?

Interventions: Mepilex Ag, Silver Sulphadiazine Ag cream.

What is the status of NCT01439074?

NCT01439074 is currently COMPLETED.

Last reviewed 2017-11-10 · How we verify

An Open, Randomized, Comparative, Multi-centre Investigation Evaluating the Efficacy and Tolerance of Mepilex Ag Versus Silver Sulfadiazine in the Treatment of Deep Partial Thickness Burn Injuries.

NCT01439074 NA COMPLETED Results posted

The purpose is to compare time to healing using absorbent foam silver dressing (Mepilex Ag) compared to a silver sulfadiazine (SSD) 1% cream in the treatment of partial thickness burn injuries.284 in-patients in 8-12 centres in China will be evaluated. Treatment period will be up to 4 weeks with either Mepilex Ag or SSD.

Details

Lead sponsor	Molnlycke Health Care AB
Phase	NA
Status	COMPLETED
Enrolment	162
Start date	2011-09
Completion	2013-09

Conditions

Burn Injuries

Interventions

Mepilex Ag
Silver Sulphadiazine Ag cream

Primary outcomes

Time to Healing — 4 weeks
Healing will be defined as number of days

Countries

China